摘要 |
This invention relates to compounds of formula (I) where R<SUP>1 </SUP>to R<SUP>12</SUP>, -W-V-, -X-Y-, p and n have the values defined in claim 1 , their preparation and use as pharmaceuticals for the treatment of central nervous system disorders, such as depression, bipolar disorder, and anxiety.
|